Zepp Health (ZEPP) Competitors $47.90 +1.50 (+3.23%) Closing price 09/19/2025 03:59 PM EasternExtended Trading$47.50 -0.41 (-0.85%) As of 09/19/2025 07:49 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ZEPP vs. NATL, DBD, PAR, VYX, EVLV, ATEN, CRSR, SSYS, CTLP, and MITKShould you be buying Zepp Health stock or one of its competitors? The main competitors of Zepp Health include NCR Atleos (NATL), Diebold Nixdorf (DBD), PAR Technology (PAR), NCR Voyix (VYX), Evolv Technologies (EVLV), A10 Networks (ATEN), Corsair Gaming (CRSR), Stratasys (SSYS), Cantaloupe (CTLP), and Mitek Systems (MITK). These companies are all part of the "computer hardware" industry. Zepp Health vs. Its Competitors NCR Atleos Diebold Nixdorf PAR Technology NCR Voyix Evolv Technologies A10 Networks Corsair Gaming Stratasys Cantaloupe Mitek Systems NCR Atleos (NYSE:NATL) and Zepp Health (NYSE:ZEPP) are both computer hardware companies, but which is the better stock? We will contrast the two companies based on the strength of their earnings, institutional ownership, valuation, risk, dividends, profitability, media sentiment and analyst recommendations. Does the media refer more to NATL or ZEPP? In the previous week, NCR Atleos and NCR Atleos both had 1 articles in the media. Zepp Health's average media sentiment score of 1.15 beat NCR Atleos' score of 0.59 indicating that Zepp Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment NCR Atleos 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Zepp Health 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is NATL or ZEPP more profitable? NCR Atleos has a net margin of 3.09% compared to Zepp Health's net margin of -38.81%. NCR Atleos' return on equity of 80.62% beat Zepp Health's return on equity.Company Net Margins Return on Equity Return on Assets NCR Atleos3.09% 80.62% 4.08% Zepp Health -38.81%-24.19%-11.36% Do analysts prefer NATL or ZEPP? NCR Atleos presently has a consensus price target of $41.00, suggesting a potential upside of 5.64%. Zepp Health has a consensus price target of $60.23, suggesting a potential upside of 25.74%. Given Zepp Health's higher possible upside, analysts plainly believe Zepp Health is more favorable than NCR Atleos.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score NCR Atleos 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 3.00Zepp Health 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do institutionals and insiders have more ownership in NATL or ZEPP? 88.7% of NCR Atleos shares are owned by institutional investors. Comparatively, 52.6% of Zepp Health shares are owned by institutional investors. 0.6% of NCR Atleos shares are owned by company insiders. Comparatively, 36.0% of Zepp Health shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Which has higher valuation & earnings, NATL or ZEPP? NCR Atleos has higher revenue and earnings than Zepp Health. Zepp Health is trading at a lower price-to-earnings ratio than NCR Atleos, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNCR Atleos$4.32B0.66$91M$1.7622.05Zepp Health$182.60M3.80-$75.73M-$4.83-9.92 Which has more risk & volatility, NATL or ZEPP? NCR Atleos has a beta of 0.99, indicating that its share price is 1% less volatile than the S&P 500. Comparatively, Zepp Health has a beta of 1.31, indicating that its share price is 31% more volatile than the S&P 500. SummaryNCR Atleos beats Zepp Health on 9 of the 14 factors compared between the two stocks. Get Zepp Health News Delivered to You Automatically Sign up to receive the latest news and ratings for ZEPP and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ZEPP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ZEPP vs. The Competition Export to ExcelMetricZepp HealthMEDICAL INFO SYS IndustryMedical SectorNYSE ExchangeMarket Cap$694.55M$2.23B$5.80B$21.58BDividend YieldN/AN/A5.61%3.51%P/E Ratio-9.9237.9680.5729.95Price / Sales3.8011.27535.4881.79Price / CashN/A59.0126.0118.30Price / Book2.7512.2015.774.64Net Income-$75.73M-$64.84M$3.30B$1.00B7 Day Performance-0.51%2.31%3.93%0.66%1 Month Performance21.24%-0.23%5.32%2.60%1 Year Performance1,351.52%35.09%80.88%14.58% Zepp Health Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ZEPPZepp Health2.5115 of 5 stars$47.90+3.2%$60.23+25.7%+1,351.5%$694.55M$182.60M-9.921,230Positive NewsNATLNCR Atleos2.4641 of 5 stars$39.68+2.4%$41.00+3.3%N/A$2.85B$4.32B22.5520,000DBDDiebold Nixdorf4.6334 of 5 stars$59.94+1.1%$75.00+25.1%+28.5%$2.17B$3.67B-176.2921,000PARPAR Technology1.7283 of 5 stars$43.18-1.9%$78.43+81.6%-24.3%$1.79B$349.98M-19.191,585VYXNCR Voyix1.5013 of 5 stars$12.85+0.4%$14.20+10.5%-4.4%$1.77B$2.83B1.8014,000Positive NewsEVLVEvolv Technologies1.9786 of 5 stars$8.43-3.8%$8.88+5.3%+79.6%$1.51B$103.86M-15.33170ATENA10 Networks4.1783 of 5 stars$17.68+1.3%$22.00+24.5%+29.6%$1.26B$261.70M25.99580Positive NewsCRSRCorsair Gaming3.8525 of 5 stars$8.94flat$9.83+10.0%+28.7%$947.97M$1.32B-11.042,567Positive NewsSSYSStratasys2.9755 of 5 stars$9.87+0.6%$14.33+45.2%+38.9%$834.77M$572.46M-7.371,779Positive NewsCTLPCantaloupe2.7936 of 5 stars$10.83+0.3%$12.55+15.9%+57.7%$792.39M$302.55M13.71220Positive NewsInsider TradeMITKMitek Systems3.3649 of 5 stars$9.97-2.6%$13.50+35.4%+16.5%$467.43M$172.08M30.21450Positive News Related Companies and Tools Related Companies NCR Atleos Alternatives Diebold Nixdorf Alternatives PAR Technology Alternatives NCR Voyix Alternatives Evolv Technologies Alternatives A10 Networks Alternatives Corsair Gaming Alternatives Stratasys Alternatives Cantaloupe Alternatives Mitek Systems Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:ZEPP) was last updated on 9/22/2025 by MarketBeat.com Staff From Our PartnersA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThis Crypto Could Thrive as Global Tensions Rise Right as capital begins to rotate back into crypto, my top...Crypto 101 Media | SponsoredWhy More Investors Are Using Family Trusts to Protect Their WealthFor many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensur...SmartAsset | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Zepp Health Corporation Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Zepp Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ZEPP Stock Alerts